Or-Yam Revach

Proud mom of two:) scientist, excited about tumor immunology and ex vivo models. Postdoctoral fellow Jenkins lab, MGH cancer center

[Or-Yam Revach @oryamush]

Proud to be part of this wonderful work in the Jenkins lab, led by Yi Sun and published in @Nature today.
We identified the kinase TBK1 in mediating tumor immune evasion and show that its targeting enhances response to PD-1 blockade. check it out!
https://t.co/OTaZeQZ5QP

[Weizmann Institute @WeizmannScience]

Yesterday we marked the International Day of Women and Girls in Science. Advancing Women in Science is a priority here at the Weizmann Institute of Science. To date, women at Weizmann constitute: 42% of PhD graduates. 20% of heads of research labs >> https://t.co/OfhGnKIoel

[Or-Yam Revach @oryamush]

#Immunotherapy #pdot #pd1

[Or-Yam Revach @oryamush]

Proud to be part of this wonderful work in the Jenkins lab, led by Yi Sun and published in @Nature today.
We identified the kinase TBK1 in mediating tumor immune evasion and show that its targeting enhances response to PD-1 blockade. check it out!
https://t.co/OTaZeQZ5QP

[Or-Yam Revach @oryamush]

Great opportunity for Israeli PhD students looking for a postdoc. Come and join our great center for cancer research @MGHCancerCenter @harvardmed

[Liron Bar-Peled @LironBarPeled]

Are you a life sciences graduate student in Israel? Have you thought about Boston for a postdoc? Checkout this wonderful opportunity from @MGHCancerCenter 👇

[Or-Yam Revach @oryamush]

Exciting @Nature milestone on T cell biology over the years! https://t.co/uKOqfaficd

[Or-Yam Revach @oryamush]

Feels like home ❤️

[Or-Yam Revach @oryamush]

Wonderful work, emphasize the importance of incorporating TME pressure in CRISPR screen for T cells function

[Julia Carnevale @jccarnevale]

Very excited to share that our work was published in @Nature today! RASA2 ablation in T cells boosts antigen sensitivity and long-term function https://t.co/q6SC7php89

[Or-Yam Revach @oryamush]

I am honored , thank you for choosing me !

[Or-Yam Revach @oryamush]

@Biana10ber Congratulations Biana! Beautiful work !

[Or-Yam Revach @oryamush]

@KarinaYaniv @WeizmannScience There is no place like the @WeizmannScience ❤️

[Or-Yam Revach @oryamush]

Thank you @Revson_Fdn for a great symposium and dinner and for your support during these last two years! It was great to meet in person and be exposed to great science @WeizmannScience @WeizmannUSA

[Or-Yam Revach @oryamush]

Magic of snow flakes ❄️❄️❄️

[Weizmann Institute @WeizmannScience]

📣Nominations now open for the Nir Friedman Prize. A #PhD student in the field of Systems Infection Biology and #Immunology will be awarded a prize of 10K ILS for their original research conducted at an Israeli university or research institution👉 https://t.co/0XZjobZnwr

[Or-Yam Revach @oryamush]

New toy in the lab! Can't wait to study tumor immunology with this @LeicaMicro #THUNDER!
@MGHCancerCenter
#tumor_immunology #Immunotherapy #organoids

[Or-Yam Revach @oryamush]

Thank you #Cambridge city conusil for voting against #BDS tonight! Let's bring here conversation, collaborations and co-exsistance #cambridge4peace

[Or-Yam Revach @oryamush]

Game changing work from @samuels_yardena lab @WeizmannScience , lead by @ShellyKalaora and @AdiNagler showing that distinct bacterial peptides presented on melanoma tumors can promote immune response and can serve as targets for immunotherapy

[yardena samuels @samuels_yardena]

A huge congratulations to Shelly Kalaora and Adi Nagler on their microbiome paper: https://t.co/oiWqPUmW91
and thanks to our wonderful collaborators- Straussman, Jen Wargo, Scott Peterson, Eytan Ruppin, Arie Admon, Pia Kvistborg, Naama Geva-Zatorsky, Eran Segal and so many more!!

[Or-Yam Revach @oryamush]

@samuels_yardena Amazing work!

[Or-Yam Revach @oryamush]

@DebattamaSen @MGHCancerCenter @harvardmed Congrats! And good luck! :)

[Eran Segal @segal_eran]

Israel:

~643,000 vaccinated (7.4% of pop)

Daily rate: 150K (1.7% of pop)

~29% of all 60+ years old vaccinated

Expect to vaccinate ~80% of all 60+ in a week

In a few days we predict lower percent of 60+ years old out of the critically ill, from ~70% today to ~40% by mid-Jan.